IRIS
CASTAGNA, ANTONELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.131
NA - Nord America 2.002
AS - Asia 699
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 11
SA - Sud America 10
OC - Oceania 5
Totale 4.875
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.978
SE - Svezia 1.377
CN - Cina 573
IT - Italia 416
FI - Finlandia 130
DE - Germania 53
IE - Irlanda 53
IN - India 42
SG - Singapore 33
RU - Federazione Russa 24
GB - Regno Unito 18
FR - Francia 17
IR - Iran 15
CA - Canada 13
EU - Europa 11
MX - Messico 10
NL - Olanda 9
BR - Brasile 7
HK - Hong Kong 7
JP - Giappone 7
PH - Filippine 7
PK - Pakistan 6
ES - Italia 5
AU - Australia 4
EG - Egitto 4
NO - Norvegia 4
UA - Ucraina 4
BE - Belgio 3
DK - Danimarca 3
HR - Croazia 3
ID - Indonesia 3
MD - Moldavia 3
RO - Romania 3
ZA - Sudafrica 3
AR - Argentina 2
CZ - Repubblica Ceca 2
MW - Malawi 2
NG - Nigeria 2
TH - Thailandia 2
TN - Tunisia 2
TR - Turchia 2
DO - Repubblica Dominicana 1
EC - Ecuador 1
ET - Etiopia 1
GH - Ghana 1
IQ - Iraq 1
KE - Kenya 1
KW - Kuwait 1
ME - Montenegro 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TZ - Tanzania 1
Totale 4.875
Salva come PNG Salva come JPEG
Città #
Lawrence 542
Princeton 542
Shenzhen 410
New York 206
Ashburn 181
Milan 180
Shanghai 144
Helsinki 126
Dublin 50
Rome 36
Washington 32
Pune 30
Seattle 25
Los Angeles 13
Genoa 11
Borås 10
Hanover 8
Bologna 6
Busto Arsizio 6
Florence 6
Lahore 6
Paris 6
Santa Clara 6
Turin 6
Campodolcino 5
Iztapalapa 5
Maringá 5
Mexico City 5
Moscow 5
Padova 5
Vittoria 5
Beijing 4
Fremont 4
Hyderabad 4
Lappeenranta 4
Liverpool 4
Madrid 4
Perm 4
Quezon City 4
Singapore 4
Sydney 4
Trondheim 4
West Jordan 4
Angera 3
Ballincollig 3
Cesano Boscone 3
Chisinau 3
Durban 3
Gatchina 3
Guardiagrele 3
Lviv 3
Messina 3
Pioltello 3
Rockville 3
Segrate 3
St Petersburg 3
Vancouver 3
Zagreb 3
Al Mansurah 2
Amsterdam 2
Andover 2
Anzio 2
Athens 2
Berlin 2
Bibiana 2
Blantyre 2
Boston 2
Bucharest 2
Casorezzo 2
Castellanza 2
Chengdu 2
Duchcov 2
Filottrano 2
Ghent 2
Gosport 2
Haywards Heath 2
Hong Kong 2
Jakarta 2
Katsina 2
Modena 2
Montreal 2
Monza 2
Novara 2
Panchkula 2
Paola 2
Petriolo 2
Ponsacco 2
Redwood City 2
Saint-Fons 2
Sestri Levante 2
Springfield 2
Tehran 2
Tokyo 2
Torino 2
Torre Del Greco 2
Tualatin 2
Varedo 2
Venezia 2
Venice 2
Verona 2
Totale 2.800
Salva come PNG Salva come JPEG
Nome #
Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population 417
Impact of Levofloxacin for Prophylaxis of Pre-engraftment Bloodstream Infections after Allogeneic HSCT: A single-center Matched Analysis in an Endemic Country for Carbapenem-resistant Gram-negative Bacteria 57
Week 96 safety and efficacy of the novel HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced participants infected with multi-drug resistant HIV-1 (BRIGHTE study) 49
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 41
null 35
Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort study 34
Continuous positive airway pressure and pronation outside the Intensive Care Unit in COVID-19 acute respiratory distress syndrome 31
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia 31
The 118I reverse transcriptase mutation is the only independent genotypic predictor of virologic failure to a stavudine-containing salvage therapy in HIV-1-infected patients 30
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency 30
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 30
Failure of on-demand pre-exposure prophylaxis: the risk of HIV drug resistance 28
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 27
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 25
Biobanking for COVID-19 research 25
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 24
Viral bloodstream detection in mpox patients: An observational multicentric study 23
PS1268 CEFTAZIDIME/AVIBACTAM AND CEFTOLOZANE/TAZOBACTAM FOR THE TREATMENT OF FEBRILE NEUTROPENIA IN ALLOGENEIC TRANSPLANT RECIPIENTS 23
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 22
Response to combination antiretroviral therapy: Variation by age 22
Brief Report: Association Between Low HIV-1 DNA and Western Blot Reactivity to HIV-1 Pol in Chronically Infected Individuals 22
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase 22
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 22
Testosterone in males with COVID-19: A twelve-month cohort study 21
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study 20
Pulmonary Vascular Thrombosis in COVID-19 Pneumonia 20
Changes in homeostatic model assessment for insulin resistance (HOMA-IR) index in treated HIV-1 infected people on virological suppression who switched to a different antiretroviral regimen 20
Severely low testosterone in males with COVID-19: a case-control study 20
Symptoms and signs of conjunctivitis as predictors of disease course in COVID-19 syndrome 20
Combined plasma levels of IL-10 and testosterone, but not soluble HLA-G5, predict the risk of death in COVID-19 patients 19
LC-MS/MS method for simultaneous determination of linezolid, meropenem, piperacillin and teicoplanin in human plasma samples 19
Dynamics of HIV-1 POL antibodies after ART in chronic HIV-1 infection 19
Allogeneic bone marrow transplantation in HIV people with hematological malignancies: Post-transplant cyclophosphamide to overcome the HLA-matching barrier 19
Subclinical myocardial dysfunction in patients recovered from COVID-19 19
Efficacy and Safety Profile of Fostemsavir for the Treatment of People with Human Immunodeficiency Virus-1 (HIV-1): Current Evidence and Place in Therapy 19
Anti-HIV antibodies are representative of the latent reservoir but do not correlate with viral control in people with long-lasting virological suppression undergoing analytical treatment interruption (APACHE study) 19
Serum IgG1 and IgG4 could contribute to partial control of viral rebound in chronically HIV-1-infected patients 19
Prior Neisseria meningitidis (Nm) proctitis does not prevent Neisseria gonorrhoeae (Ng) proctitis among men who have sex with men (MSM) 18
A follow-up study in asymptomatic HIV patients 18
Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial 18
VIRO-immunological outcomes after 13-valent pneumococcal vaccination in HIV-1-infected individuals on stable virological suppression 18
Cerebrospinal fluid viral replication and burden of resistance in three HIV-1-infected people taking Ibalizumab with multiple drug class-wide resistance 18
Rugarli. Medicina interna sistematica 18
Circulating cathodic antigen (CCA) urine rapid test for diagnosis of Schistosoma mansoni infestation: preliminary data of a cohort study of Egyptian patients coming from an endemic area 18
Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium 18
Cardiac implantable electronic device infections: impact of initiation of antimicrobial treatment before or after device removal on microbiological yield 17
Zidovudine and frequency of HIV-induced diffuse leukoencephalopathy 17
Analytical treatment interruption in chronic HIV-1 infection: Time and magnitude of viral rebound in adults with 10 years of undetectable viral load and low HIV-DNA (APACHE study) 17
Switching antiretrovirals in older patients 17
Retrospective study on the outcome of two-drug regimens based on dolutegravir plus one reverse transcriptase inhibitor in virologically-suppressed HIV-infected patients 17
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study 17
Myocardial injury in patients with SARS-CoV-2 pneumonia: pivotal role of inflammation in COVID-19 17
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study 16
Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study 16
Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients 16
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study) 16
Infections after Allogenic Transplant with Post-Transplant Cyclophosphamide: Impact of Donor HLA Matching 16
SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic 16
Western blot in treated people with HIV-1 chronic infection: frequency of negative HIV-1 pol genes 16
A comparision of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patients 16
Role of blood pressure dysregulation on kidney and mortality outcomes in COVID-19. Kidney, blood pressure and mortality in SARS-CoV-2 infection 16
Neutralizing monoclonal antibodies for the treatment and prophylaxis of SARS-CoV-2 infection 16
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 15
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 15
COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike Receptor Binding Domain 15
HIV-DNA undetectability during chronic HIV infection: Frequency and predictive factors 15
Erratum: Correction to: Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIV (BMC infectious diseases (2021) 21 1 (557)) 15
Ribavirin Aerosol in the Treatment of SARS-CoV-2: A Case Series 15
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses 14
Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice 14
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia 14
In vivo dynamics of the 103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in HIV-infected patients: Preliminary results 14
Cerebrospinal fluid beta 2-microglobulin in AIDS related central nervous system involvement. 14
Key questions in antiretroviral therapy: Italian Consensus Workshop (2005) 14
Pharmacokinetics of the raltegravir/maraviroc/etravirine combination 14
CD4 Cell Count and the Risk of AIDS or Death in HIV-Infected Adults on Combination Antiretroviral Therapy with a Suppressed Viral Load: A Longitudinal Cohort Study from COHERE 14
Mortality in migrants living with HIV in western Europe (1997-2013): A collaborative cohort study 14
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 14
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 14
Rhodococcus defluvii pneumonia: First reported case in humans 14
Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study 14
Impact of multi-drug resistance on mortality: a multi-cohort Italian study 14
Viral resistance burden and APOBEC editing correlate with virological response in heavily treatment-experienced people living with multi-drug resistant HIV 14
Levels of Alpha-Fetoprotein and Association with Mortality in Hepatocellular Carcinoma of HIV-1-Infected Patients 13
A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients: the MaxCmin2 trial 13
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection 13
Diagnostic accuracy of APRI, FIB-4 and Forns for the detection of liver cirrhosis in HIV/HCV-coinfected patients 13
Estimated glomerular filtration rate trajectories in HIV-infected subjects treated with different ritonavir-boosted protease inhibitors and tenofovir disoproxil fumarate or abacavir 13
Atazanavir/ritonavir monotherapy: 96 week efficacy, safety and bone mineral density from the MODAt randomized trial 13
Homeostatic model assessment for insulin resistance index trajectories in HIV-infected patients treated with different first-line antiretroviral regimens 13
Evolving treatment implementation among HIV- infected pregnant women and their partners: Results from a national surveillance study in Italy, 2001-2015 13
Drop in CD4+ Counts Below 200 Cells/μL After Reaching (or Starting From) Values Higher than 350 Cells/μL in HIV-Infected Patients With Virological Suppression 13
Osteopenia/osteoporosis in highly-experienced HIV-infected patients 13
T and B cell responses to cytomegalovirus antigens in healthy blood donors and bone marrow transplant recipients 13
HEFFICON: HIV Effectiveness Italian Conference 13
Testosterone in males with COVID-19: A 7-month cohort study 13
Inflammation and microbial translocation measured prior to combination antiretroviral therapy (cART) and long-term probability of clinical progression in people living with HIV 13
Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort 13
Disseminated Mycobacterium chimaera infection favoring the development of Kaposi’s sarcoma: a case report 12
Beyond stigma: Monkeypox infection in a 27-year-old woman 12
Totale 2.285
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.345
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.345
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202073 71 0 0 0 0 0 0 0 0 0 1 1
2020/2021235 2 0 1 23 0 51 11 131 5 0 7 4
2021/2022417 1 0 0 137 26 29 36 64 36 29 16 43
2022/20232.833 1.206 552 220 27 36 257 174 185 98 19 35 24
2023/20241.809 45 66 641 171 178 408 59 180 8 45 8 0
Totale 5.724